Neuroprotective Effects and Cognitive Support Recent studies suggest that BPC-157 may have neuroprotective properties, meaning it could support brain and nerve healing
Human clinical applications are unproven
In the 1 mg trial arm, liver fat fell 51% among participants with fatty liver, visceral fat fell 16%, triglycerides declined, and ketones rose as the liver used more fat. Modeled metabolic-health protocols place heavier, metabolically average profiles near 1 mg weekly
Independent Third-Party Testing Available Upon Request for Added Assurance
By enhancing metabolic efficiency, AOD9604 contributes to a balanced and energized lifestyle
Dosing Equivalency Unknown: There is no established conversion factor between oral and injectable dosing based on human clinical trials